YMTX

NASDAQ

Yumanity Therapeutics Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2016

News25/Ratings0

Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. It focuses on discovering disease-modifying therapies to treat Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer's diseases. Its lead program is YTX-7739, a novel small molecule for the treatment of Parkinson's disease and related disorders of a-synuclein that is in Phase I clinical trial. The company is also developing YTX-9184 for the treatment of dementia with Lewy bodies. Yumanity Therapeutics Inc. has a strategic research and development collaboration agreement with Merck Sharp & Dohme Corp. The company is headquartered in Boston, Massachusetts.

Latest news

25 items

799d13D/G
SEC Form SC 13G filed by Yumanity Therapeutics Inc.
SC 13G - KINETA, INC./DE (0001445283) (Subject)
801d13D/G
SEC Form SC 13D/A filed by Yumanity Therapeutics Inc. (Amendment)
SC 13D/A - KINETA, INC./DE (0001445283) (Subject)
801d13D/G
SEC Form SC 13G/A filed by Yumanity Therapeutics Inc. (Amendment)
SC 13G/A - KINETA, INC./DE (0001445283) (Subject)
827dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
839dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
860dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
869dINSIDER
Bartoszek Raymond J. bought $9,950 worth of shares (2,250 units at $4.42), increasing direct ownership by 15% to 17,206 units (SEC Form 4)
4 - KINETA, INC./DE (0001445283) (Issuer)
875dINSIDER
Philips Craig W. bought $9,812 worth of shares (3,000 units at $3.27), increasing direct ownership by 5% to 60,811 units (SEC Form 4)
4 - KINETA, INC./DE (0001445283) (Issuer)
875dINSIDER
Iadonato Shawn bought $17,398 worth of shares (5,000 units at $3.48), increasing direct ownership by 0.75% to 675,230 units (SEC Form 4)
4 - KINETA, INC./DE (0001445283) (Issuer)
891dSEC
SEC Form EFFECT filed by Yumanity Therapeutics Inc.
EFFECT - KINETA, INC./DE (0001445283) (Filer)
892dSEC
SEC Form 424B3 filed by Yumanity Therapeutics Inc.
424B3 - KINETA, INC./DE (0001445283) (Filer)
899dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
902dSEC
SEC Form S-3 filed by Yumanity Therapeutics Inc.
S-3 - KINETA, INC./DE (0001445283) (Filer)
902dSEC
SEC Form 10-Q filed by Yumanity Therapeutics Inc.
10-Q - KINETA, INC./DE (0001445283) (Filer)
902dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
902dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
916dSEC
SEC Form D filed by Yumanity Therapeutics Inc.
D - KINETA, INC./DE (0001445283) (Filer)
919dSEC
SEC Form 8-K filed by Yumanity Therapeutics Inc.
8-K - KINETA, INC./DE (0001445283) (Filer)
924dINSIDER
Foote Marion R exercised 4,443 shares at a strike of $0.14, increasing direct ownership by 3% to 143,204 units (SEC Form 4)
4 - KINETA, INC./DE (0001445283) (Issuer)
931dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
931dSEC
SEC Form 424B5 filed by Yumanity Therapeutics Inc.
424B5 - KINETA, INC./DE (0001445283) (Filer)
932dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
933dSEC
Yumanity Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - KINETA, INC./DE (0001445283) (Filer)
945dINSIDER
SEC Form 4: Philips Craig W. bought $8,495 worth of shares (3,500 units at $2.43), increasing direct ownership by 6% to 57,811 units
4 - KINETA, INC./DE (0001445283) (Issuer)
945dINSIDER
SEC Form 4: Kenny Pauline bought $3,870 worth of shares (1,500 units at $2.58), increasing direct ownership by 9% to 18,448 units
4 - KINETA, INC./DE (0001445283) (Issuer)